Extract notice to the Minister

Keytruda SC (indications diverses)

Common name / Subject : pembrolizumab
Name of the manufacturer : Merck
Form : Sol. Inj. S.C. (fiole)
Dosage : 165 mg/ml (2,4 ml), 165 mg/ml (4,8 ml)

Indication : Indications diverses (oncologie)

INESSS' Recommendation
Inscription – Sous conditions

Minister's decisions
À venir

Evaluation published on July 28, 2026

INESSSid: 30139
Recevable on February 16, 2026

Download Advice to minister about Keytruda SC (indications diverses)

Extrait d'avis à la ministre sur Keytruda SC 740 KiO

Subscribe to our newsletter now

Subscription